150 related articles for article (PubMed ID: 28382148)
1. NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer.
Wu J; Wan F; Sheng H; Shi G; Shen Y; Lin G; Dai B; Zhu Y; Ye D
J Cancer; 2017; 8(5):852-860. PubMed ID: 28382148
[TBL] [Abstract][Full Text] [Related]
2. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
Lu X; Wan F; Zhang H; Shi G; Ye D
Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
[TBL] [Abstract][Full Text] [Related]
3. Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer.
Abudurexiti M; Xie H; Jia Z; Zhu Y; Zhu Y; Shi G; Zhang H; Dai B; Wan F; Shen Y; Ye D
Front Oncol; 2019; 9():856. PubMed ID: 31552180
[TBL] [Abstract][Full Text] [Related]
4. NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma.
Wang Y; Wan F; Chang K; Lu X; Dai B; Ye D
Oncol Lett; 2017 Nov; 14(5):6121-6128. PubMed ID: 29113256
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Predictive Value of O
Zhang J; Zhu Y; Wang Y; Fu Q; Xie H; Liu Z; Fu H; Cao Y; Xu J; Dai B
Ann Surg Oncol; 2018 Jan; 25(1):342-348. PubMed ID: 29116491
[TBL] [Abstract][Full Text] [Related]
6. SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.
Gu W; Wang B; Wan F; Wu J; Lu X; Wang H; Zhu Y; Zhang H; Shi G; Dai B; Ye D
Oncol Lett; 2018 Apr; 15(4):4564-4570. PubMed ID: 29541226
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
8. Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer.
Zhang S; Wang C; Xia W; Duan H; Qian S; Shen H
Int J Gen Med; 2021; 14():8651-8666. PubMed ID: 34849009
[TBL] [Abstract][Full Text] [Related]
9. CD19
Jiang Q; Fu Q; Chang Y; Liu Z; Zhang J; Xu L; Zhu Y; Wang Y; Zhang W; Xu J
Cancer Immunol Immunother; 2019 Jan; 68(1):45-56. PubMed ID: 30259082
[TBL] [Abstract][Full Text] [Related]
10. High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
Burgess EF; Livasy C; Trufan S; Hartman A; Guerreri R; Naso C; Clark PE; Grigg C; Symanowski J; Raghavan D
Urol Oncol; 2019 Dec; 37(12):900-906. PubMed ID: 31597600
[TBL] [Abstract][Full Text] [Related]
11. Poliovirus receptor CD155 is up-regulated in muscle-invasive bladder cancer and predicts poor prognosis.
Zhang J; Zhu Y; Wang Q; Kong Y; Sheng H; Guo J; Xu J; Dai B
Urol Oncol; 2020 Feb; 38(2):41.e11-41.e18. PubMed ID: 31383549
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of EGFR, AREG and EREG amplification and gene expression in muscle invasive bladder cancer.
Uysal D; Thaqi B; Fierek A; Jurgowski D; Popovic ZV; Siegel F; Michel MS; Nuhn P; Worst TS; Erben P; Nitschke K
Front Oncol; 2024; 14():1370303. PubMed ID: 38868531
[TBL] [Abstract][Full Text] [Related]
13. B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.
Xie H; Zhu Y; Zhang J; Liu Z; Fu H; Cao Y; Li G; Shen Y; Dai B; Xu J; Ye D
BMC Cancer; 2018 May; 18(1):590. PubMed ID: 29793447
[TBL] [Abstract][Full Text] [Related]
14. FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer.
Kang HW; Yoon HY; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim WJ
Korean J Urol; 2012 Sep; 53(9):598-606. PubMed ID: 23060996
[TBL] [Abstract][Full Text] [Related]
15. Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients.
Jin S; Zeng H; Liu Z; Jin K; Liu C; Yan S; Yu Y; You R; Zhang H; Chang Y; Xu L; Xu J; Wang Z; Zhu Y
Ann Surg Oncol; 2022 Apr; 29(4):2495-2503. PubMed ID: 35000080
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer.
Cao DL; Dai WX; Huang YQ; Yu LJ; Wu JL; Shi GH; Zhang HL; Zhu Y; Dai B; Ye DW
J Cancer; 2020; 11(5):997-1007. PubMed ID: 31956346
[No Abstract] [Full Text] [Related]
17. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ
Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049
[TBL] [Abstract][Full Text] [Related]
18. Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients.
Eckstein M; Jung R; Weigelt K; Sikic D; Stöhr R; Geppert C; Agaimy A; Lieb V; Hartmann A; Wullich B; Wach S; Taubert H
Sci Rep; 2018 Dec; 8(1):17693. PubMed ID: 30523270
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.
Del Bene G; Calabrò F; Giannarelli D; Plimack ER; Harshman LC; Yu EY; Crabb SJ; Pal SK; Alva AS; Powles T; De Giorgi U; Agarwal N; Bamias A; Ladoire S; Necchi A; Vaishampayan UN; Niegisch G; Bellmunt J; Baniel J; Galsky MD; Sternberg CN
Front Oncol; 2018; 8():463. PubMed ID: 30510914
[No Abstract] [Full Text] [Related]
20. Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma.
Wang Y; Li G; Wan F; Dai B; Ye D
Oncol Lett; 2018 Jul; 16(1):866-874. PubMed ID: 29963157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
